197 related articles for article (PubMed ID: 36915449)
1. Prognostic nutritional index predicts the prognosis of patients with advanced esophageal cancer treated with immune checkpoint inhibitors: a retrospective cohort study.
Wu M; Zhu Y; Chen X; Wang X; Lin X; Yan X; Mo P; Ye Y; Zeng Y; Yang Y; Fu Z
J Gastrointest Oncol; 2023 Feb; 14(1):54-63. PubMed ID: 36915449
[TBL] [Abstract][Full Text] [Related]
2. Nutritional status as prognostic factor of advanced oesophageal cancer patients treated with immune checkpoint inhibitors.
Chen N; Yu Y; Shen W; Xu X; Fan Y
Clin Nutr; 2024 Jan; 43(1):142-153. PubMed ID: 38043419
[TBL] [Abstract][Full Text] [Related]
3. Prognostic roles of hematological indicators for the efficacy and prognosis of immune checkpoint inhibitors in patients with advanced tumors: a retrospective cohort study.
Zheng F; Meng Q; Zhang L; Chen J; Zhao L; Zhou Z; Liu Y
World J Surg Oncol; 2023 Jul; 21(1):198. PubMed ID: 37420219
[TBL] [Abstract][Full Text] [Related]
4. Use of the prognostic nutrition index as a predictive biomarker in small-cell lung cancer patients undergoing immune checkpoint inhibitor treatment in the Chinese alpine region.
Wu Y; Yang J; Qiao X; Li Y; Zhao R; Lin T; Li X; Wang M
Front Oncol; 2023; 13():1041140. PubMed ID: 37007079
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
[TBL] [Abstract][Full Text] [Related]
6. Prognostic nutritional index for predicting the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors.
Sun H; Chen L; Huang R; Pan H; Zuo Y; Zhao R; Xue Y; Song H
Front Nutr; 2022; 9():1038118. PubMed ID: 36438745
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of nutritional indicators with regard to the survival outcomes in patients with metastatic esophageal squamous cell carcinoma treated with camrelizumab.
Liu J; Hu G; Zhai C; Wang J; Xu W; Xie J; Zhu W; Jiang P; Liu D
Oncol Lett; 2023 May; 25(5):198. PubMed ID: 37113404
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Nutritional Index Predicts Outcome of PD-L1 Negative and MSS Advanced Cancer Treated with PD-1 Inhibitors.
Zhang Y; Jin J; Tang M; Li P; Zhou LN; Du YP; Chen MB
Biomed Res Int; 2022; 2022():6743126. PubMed ID: 35707390
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy.
Pan Y; Ma Y; Dai G
Nutrients; 2023 Oct; 15(19):. PubMed ID: 37836573
[TBL] [Abstract][Full Text] [Related]
10. A Nutrition-Related Factor-Based Risk Stratification for Exploring the Clinical Benefits in the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: A Retrospective Cohort Study.
Yu Y; Wu H; Qiu J; Ke D; Wu Y; Lin M; Liu T; Zheng Q; Zheng H; Yang J; Wang Z; Li H; Liu L; Yao Q; Li J; Cheng W; Chen X
Front Nutr; 2022; 9():896847. PubMed ID: 35990358
[TBL] [Abstract][Full Text] [Related]
11. [Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors].
Zhu WJ; Zhu HH; Liu YT; Lin L; Xing PY; Hao XZ; Cong MH; Wang HY; Wang Y; Li JL; Feng Y; Hu XS
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):416-424. PubMed ID: 35615798
[No Abstract] [Full Text] [Related]
12. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic nutritional index as a reliable prognostic indicator for advanced lung cancer patients receiving immune checkpoint inhibitors.
Yan X; Wang J; Mao J; Wang Y; Wang X; Yang M; Qiao H
Front Nutr; 2023; 10():1213255. PubMed ID: 37575320
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Nutritional Index Associates with Immunotherapy Response in Patients with Metastatic Biliary Tract Cancer.
Yang L; Zhong J; Wang W; Zhou F
Nutr Cancer; 2023; 75(2):696-706. PubMed ID: 36511876
[No Abstract] [Full Text] [Related]
15. Impact of the pretreatment prognostic nutritional index on the survival after first-line immunotherapy in non-small-cell lung cancer patients.
Oku Y; Toyokawa G; Wakasu S; Kinoshita F; Takamori S; Watanabe K; Haratake N; Nagano T; Kosai K; Takada K; Fujimoto A; Higashijima K; Shiraishi Y; Tanaka K; Takeoka H; Okamoto M; Yamashita T; Shimokawa M; Shoji F; Yamazaki K; Okamoto T; Seto T; Ueda H; Takeo S; Nakashima N; Okamoto I; Takenaka T; Yoshizumi T
Cancer Med; 2023 Jul; 12(13):14327-14336. PubMed ID: 37211905
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of prognostic nutritional index in advanced cancer receiving PD-1/L1 inhibitors: A meta-analysis.
Li P; Lai Y; Tian L; Zhou Q
Cancer Med; 2022 Aug; 11(16):3048-3056. PubMed ID: 35297197
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood nutrient indices as biomarkers for anti‑PD‑1 therapy efficacy and prognosis in patients with advanced gastric cancer.
Wang X; Liu X; Dai H; Jia J
Oncol Lett; 2023 Sep; 26(3):397. PubMed ID: 37600335
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy.
Nakatani M; Migita K; Matsumoto S; Wakatsuki K; Ito M; Nakade H; Kunishige T; Kitano M; Kanehiro H
Dis Esophagus; 2017 Aug; 30(8):1-7. PubMed ID: 28575242
[TBL] [Abstract][Full Text] [Related]
19. Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study.
Ding P; Guo H; Sun C; Yang P; Kim NH; Tian Y; Liu Y; Liu P; Li Y; Zhao Q
BMC Gastroenterol; 2022 Mar; 22(1):121. PubMed ID: 35287591
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
Wang J; Liu Y; Mi X; Shao M; Liu L
Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]